Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

  • Post author:
  • Post category:uncategorized

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising immune responses and improved recurrence-free survival in high-risk triple-negative breast cancer patients.